Abstract |
In this study, we present in vitro cytotoxicity of iron oxide (Fe(3)O(4)) and manganese oxide (MnO) using live/dead cell assay, lactate dehydrogenase assay, and reactive oxygen species detection with variation of the concentration of nanoparticles (5-500 microg/ml), incubation time (18-96 h), and different human cell lines ( lung adenocarcinoma, breast cancer cells, and glioblastoma cells). The surface of nanoparticles is modified with polyethyleneglycol-derivatized phospholipid to enhance the biocompatibility, water-solubility, and stability under an aqueous media. While the cytotoxic effect was negligible for 18 h incubation even at highest concentration of 500 microg/ml, MnO nanoparticle represented higher level of toxicity than those of Fe(3)O(4) and the commercial medical contrast reagent, Feridex after 2 and 4 day incubation time. However, the cytotoxicity of Fe(3)O(4) is equivalent or better than Feridex based on the live/dead cell viability assay. The engineered MnO and Fe(3)O(4) exhibited excellent stability compared with Feridex for a prolonged incubation time.
|
Authors | Jong Young Choi, Su Hee Lee, Hyon Bin Na, Kwangjin An, Taeghwan Hyeon, Tae Seok Seo |
Journal | Bioprocess and biosystems engineering
(Bioprocess Biosyst Eng)
Vol. 33
Issue 1
Pg. 21-30
(Jan 2010)
ISSN: 1615-7605 [Electronic] Germany |
PMID | 19636592
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Ferric Compounds
- Manganese Compounds
- Oxides
- ferric oxide
- manganese oxide
|
Topics |
- Biological Assay
(methods)
- Cell Culture Techniques
- Cell Line, Tumor
- Dose-Response Relationship, Drug
- Ferric Compounds
(adverse effects)
- Humans
- Manganese Compounds
(adverse effects)
- Materials Testing
(methods)
- Nanoparticles
(adverse effects)
- Oxides
(adverse effects)
- Time Factors
|